Framework_About us_HONGGUAN BIO-PHARMA CO.,LTD.

Company introduction

Hong Guan Biological Pharmaceutical Co., Ltd. was founded in 2013, is located in Zhejiang city of Tongxiang Province, only 10 km away from the southern town of Wuzhen, covers an area of 252.73 mu, the registered capital of 120 million yuan, the existing staff of more than 200 people in the United States, the National Academy of Sciences, academician of the Chinese Academy of Sciences for the development of core strength, to innovative drug research and development as the main line focus in the field of anti-tumor, analgesic, diabetes, and cardiovascular; is a research, production, marketing, logistics as one of the large modern high-tech pharmaceutical group.


We are committed to developing and producing high quality pharmaceutical products with high technology content, safety and efficacy, serving the health of the masses, promoting the progress of industry and paying attention to social concerns.


We are committed to the development and production of high quality, safe and effective high quality medicine.

Products, to serve the public health, promote the progress of the industry, and return social care.

We are committed to the development and production of high-tech, safe, effective and accurate high-quality medicine

Public health products and services to promote industry progress, return social care.

We are committed to the development and production of high-tech, safe, effective and accurate high-quality medicine

Public health products and services to promote industry progress, return social care.

We are committed to the development and production of high quality, safe and effective high quality medicine.

Products, to serve the public health, promote the progress of the industry, and return social care.

The company has been selected into "major industrial projects in Zhejiang province", "major industrial projects in Zhejiang province" and "key construction projects in Zhejiang province"

"Ginsenoside CK project" and "IDH project" were selected for 2017 national major new drug creation special.

The pharmaceutical logistics and storage project was selected as the key replenishing chain project of Tongxiang Economic Development Zone's circular transformation, and was supported by the provincial development and Reform Commission and the national development and Reform Commission. 

Chairman's speech

Adhering to the strong driving force of the capital market, we are committed to building the brand's brilliance with sincerity and creating a new chapter in the vigorous development of Chinese medicine by adhering to the powerful driving force of the capital market.

未标题-10.jpg